North America Cough Remedies Market Size, Share & Trends Analysis Report By Age (Adult and Pediatric), By Distribution Channel (Retail Pharmacy, Hospital and Online Pharmacies), By Type, By Dosage. By Country and Growth Forecast, 2023 - 2030

The North America Cough Remedies Market would witness market growth of 4.8% CAGR during the forecast period (2023-2030).

The US market dominated the North America Cough Remedies Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,647.1 million by 2030. The Canada market is experiencing a CAGR of 7.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 6.3% during (2023 - 2030).



Cough, a common symptom of various respiratory conditions, ranging from the common cold to chronic obstructive pulmonary disease (COPD), represents a significant health concern. The widespread utilization of cough remedies among individuals of all ages and demographics is an impetus for growth and advancement in the healthcare industry. The adoption of cough remedies is driven by the universal desire to alleviate discomfort and improve quality of life during respiratory illnesses. Cough significantly burdens individuals, disrupting sleep, impairing productivity, and impacting overall well-being. Consequently, consumers seek accessible and effective solutions to manage cough symptoms, driving demand for diverse cough remedies tailored to their preferences and needs.

Additionally, growing consumer awareness and preference for natural products have fueled the demand for herbal and botanical cough remedies. Ingredients such as eucalyptus, menthol, and licorice root are gaining prominence for their purported therapeutic properties in soothing cough symptoms and supporting respiratory health. Eucalyptus is a well-known botanical remedy widely utilized in cough remedies for its respiratory benefits.

The number of instances of chronic obstructive pulmonary disease (COPD) in the US has been steadily increasing in recent years. In the US, smoking is still one of the main causes of COPD. Despite significant public health campaigns and smoking cessation efforts, a considerable portion of the population continues to smoke or has a history of smoking, leading to an increased risk of developing COPD. Thus, the rising e-commerce trends and COPD cases in North America will assist in the growth of the regional cough remedies market.

Based on Age, the market is segmented into Adult and Pediatric. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital and Online Pharmacies. Based on Type, the market is segmented into Expectorants, Antihistamines, Bronchodilators, Antibiotics and Others. Based on Dosage, the market is segmented into Oral Syrup, Tablets & Pills, Lozenges, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Himalaya Global Holdings Ltd.
• Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
• Pfizer, Inc.
• Amway Corporation
• NOW Foods, Inc.
• Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
• Nu Skin Enterprises, Inc.
• Nature’s Sunshine Products, Inc.
• Neurobiologix, Inc.
• Nordic Naturals, Inc.

Market Report Segmentation

By Age

• Adult
• Pediatric

By Distribution Channel

• Retail Pharmacy
• Hospital
• Online Pharmacies

By Type

• Expectorants
• Antihistamines
• Bronchodilators
• Antibiotics
• Others

By Dosage

• Oral Syrup
• Tablets & Pills
• Lozenges
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America